We are pleased to announce that we have agreed to be acquired by Blackstone and TPG for up to $79 per share, or an enterprise value of up to $18.3 billion. With their deep resources and expertise, we believe Blackstone and TPG will bolster Hologic’s already strong product positions and enhance Hologic’s ability to deliver critical medical technologies that benefit customers and patients globally. Stephen P. MacMillan, Hologic’s Chairman, President and Chief Executive Officer, said, “Today marks